These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16465710)

  • 1. Does health technology assessment put patient care at risk?
    McEwan AJ
    J Nucl Med; 2005 Dec; 46(12):1939. PubMed ID: 16465710
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear medicine usage grows, led by PET.
    J Nucl Med; 2006 Oct; 47(10):13N. PubMed ID: 17061396
    [No Abstract]   [Full Text] [Related]  

  • 3. Problems of using modelling in the economic evaluation of health care.
    Sheldon TA
    Health Econ; 1996; 5(1):1-11. PubMed ID: 8653188
    [No Abstract]   [Full Text] [Related]  

  • 4. Joint project of the International Network of Agencies for Health Technology Assessment--Part 2: Managing the diffusion of positron emission tomography with health technology assessment.
    Adams EJ; Almazán C; Mørland B; Bradbury I; King R; Rheinberger P
    Int J Technol Assess Health Care; 2006; 22(2):149-54. PubMed ID: 16571189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology and human choices in health care.
    Chenoy N
    Health Manage Forum; 1980; 1(2):47-54. PubMed ID: 10248634
    [No Abstract]   [Full Text] [Related]  

  • 6. Promoting nuclear medicine in developing countries through IAEA coordinated research projects: Technical Reports Series 458 and 459.
    Duatti A
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):209-11. PubMed ID: 18551092
    [No Abstract]   [Full Text] [Related]  

  • 7. Technology assessment in reducing costs and improving care.
    Jacox A
    Nurs Econ; 1990; 8(2):116, 118. PubMed ID: 2330062
    [No Abstract]   [Full Text] [Related]  

  • 8. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET versus SPECT: strengths, limitations and challenges.
    Rahmim A; Zaidi H
    Nucl Med Commun; 2008 Mar; 29(3):193-207. PubMed ID: 18349789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High technology health care.
    Lamm RD
    Natl Forum; 1989; 69(4):14-7. PubMed ID: 16100835
    [No Abstract]   [Full Text] [Related]  

  • 11. Physics in nuclear medicine: a year of tangible progress.
    Stabin M; Brill AB
    J Nucl Med; 2003 Jan; 44(1):22N-25N. PubMed ID: 12524696
    [No Abstract]   [Full Text] [Related]  

  • 12. National Center for Health Care Technology: an important resource for health care delivery.
    Sanders CA
    Med Instrum; 1981; 15(5):299-301. PubMed ID: 7321925
    [No Abstract]   [Full Text] [Related]  

  • 13. Is PET the future of nuclear medicine?
    Maisey M
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1045-6. PubMed ID: 12827314
    [No Abstract]   [Full Text] [Related]  

  • 14. Is PET the future of nuclear medicine?
    Bailey DL
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1047-9. PubMed ID: 12811533
    [No Abstract]   [Full Text] [Related]  

  • 15. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.
    Basu S; Alavi A
    J Nucl Med; 2008 Oct; 49(10):17N-21N, 37N. PubMed ID: 18832112
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmeeting summary on the round table discussion at the Seventh International Symposium on Technetium in Chemistry and Nuclear Medicine held in Bressanone, Italy on Sept 6-9, 2006.
    Eckelman WC; Erba PA; Schwaiger M; Wagner HN; Alberto R; Mazzi U
    Nucl Med Biol; 2007 Jan; 34(1):1-4. PubMed ID: 17210456
    [No Abstract]   [Full Text] [Related]  

  • 17. Technology assessment, managed healthcare and nuclear medicine.
    Papatheofanis FJ
    J Nucl Med; 1997 Jul; 38(7):13N-14N. PubMed ID: 9225777
    [No Abstract]   [Full Text] [Related]  

  • 18. Methodology for calculating a country's need for positron emission tomography scanners.
    Cleemput I; Camberlin C; Van den Bruel A; Ramaekers D
    Int J Technol Assess Health Care; 2008; 24(1):20-4. PubMed ID: 18218165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technology assessment (HTA) groups have been instrumental in restricting patient access to PET worldwide.
    Ware R
    J Nucl Med; 2004 Dec; 45(12):1977. PubMed ID: 15641205
    [No Abstract]   [Full Text] [Related]  

  • 20. Spatial dose mapping for individualizing radioiodine treatment.
    Lassmann M; Hänscheid H
    J Nucl Med; 2007 Jan; 48(1):2-4. PubMed ID: 17204691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.